IL6 and hepatocellular carcinoma: Active IL-27 receptor signaling was previously shown to reduce the expression of IL-6 and other inflammatory cytokines deemed pro-tumorigenic in HCC [126] and in another study, IL-27 was shown to have a similar function as IFN-γ and tends to be inhibited by IL-6 [127].